GlassScriptPhysician profile
Jorg Dietrich
NPI 1407977473
$26,587.09
in general payments reported to CMS, 2019-2025
8 companies · $3,220 in 2025
The $3,220 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,933 · 2021: $525 · 2022: $3,366 · 2023: $7,716 · 2024: $6,827 · 2025: $3,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $620 · Food and Beverage: $76.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,065.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $620.00 |
| Food and Beverage | $76.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $10,331.75 | 2022-2023 | |
| Janssen Research & Development, LLC | $6,826.96 | 2024 | Carvykti, Tecvayli |
| Blue Earth Diagnostics | $3,958.38 | 2019-2021 | |
| Telix Pharmaceuticals | $2,600.00 | 2025 | |
| Biogen, INC. | $1,500.00 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $750.00 | 2023 | |
| Deciphera Pharmaceuticals INC. | $620.00 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorg Dietrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.